Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 319

Similar articles for PubMed (Select 18272579)


The role of T cells in the enhancement of respiratory syncytial virus infection severity during adult reinfection of neonatally sensitized mice.

Tregoning JS, Yamaguchi Y, Harker J, Wang B, Openshaw PJ.

J Virol. 2008 Apr;82(8):4115-24. doi: 10.1128/JVI.02313-07. Epub 2008 Feb 13.


Infection of mice with respiratory syncytial virus during neonatal life primes for enhanced antibody and T cell responses on secondary challenge.

Tasker L, Lindsay RW, Clarke BT, Cochrane DW, Hou S.

Clin Exp Immunol. 2008 Aug;153(2):277-88. doi: 10.1111/j.1365-2249.2008.03591.x. Epub 2008 Jun 28.


Transfer of the enhancing effect of respiratory syncytial virus infection on subsequent allergic airway sensitization by T lymphocytes.

Schwarze J, Mäkelä M, Cieslewicz G, Dakhama A, Lahn M, Ikemura T, Joetham A, Gelfand EW.

J Immunol. 1999 Nov 15;163(10):5729-34.


CD8+ T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection.

Hussell T, Baldwin CJ, O'Garra A, Openshaw PJ.

Eur J Immunol. 1997 Dec;27(12):3341-9.


Host genetic determinants of vaccine-induced eosinophilia during respiratory syncytial virus infection.

Hussell T, Georgiou A, Sparer TE, Matthews S, Pala P, Openshaw PJ.

J Immunol. 1998 Dec 1;161(11):6215-22.


Pulmonary V gamma 4+ gamma delta T cells have proinflammatory and antiviral effects in viral lung disease.

Dodd J, Riffault S, Kodituwakku JS, Hayday AC, Openshaw PJ.

J Immunol. 2009 Jan 15;182(2):1174-81.


CD8 T cells are essential in the development of respiratory syncytial virus-induced lung eosinophilia and airway hyperresponsiveness.

Schwarze J, Cieslewicz G, Joetham A, Ikemura T, Hamelmann E, Gelfand EW.

J Immunol. 1999 Apr 1;162(7):4207-11.


Regulatory T cells promote early influx of CD8+ T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparities.

Ruckwardt TJ, Bonaparte KL, Nason MC, Graham BS.

J Virol. 2009 Apr;83(7):3019-28. doi: 10.1128/JVI.00036-09. Epub 2009 Jan 19.


CD8 T cells inhibit respiratory syncytial virus (RSV) vaccine-enhanced disease.

Olson MR, Varga SM.

J Immunol. 2007 Oct 15;179(8):5415-24.


Virus-specific IgE enhances airway responsiveness on reinfection with respiratory syncytial virus in newborn mice.

Dakhama A, Lee YM, Ohnishi H, Jing X, Balhorn A, Takeda K, Gelfand EW.

J Allergy Clin Immunol. 2009 Jan;123(1):138-145.e5. doi: 10.1016/j.jaci.2008.10.012. Epub 2008 Dec 3.


Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease.

Castilow EM, Olson MR, Varga SM.

Immunol Res. 2007;39(1-3):225-39. Review.


STAT4 deficiency fails to induce lung Th2 or Th17 immunity following primary or secondary respiratory syncytial virus (RSV) challenge but enhances the lung RSV-specific CD8+ T cell immune response to secondary challenge.

Dulek DE, Newcomb DC, Toki S, Goliniewska K, Cephus J, Reiss S, Bates JT, Crowe JE Jr, Boyd KL, Moore ML, Zhou W, Peebles RS Jr.

J Virol. 2014 Sep 1;88(17):9655-72. doi: 10.1128/JVI.03299-13. Epub 2014 Jun 11.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk